Search

everythinglearnresearchcommunity

for

Search:↓

Dermatologists are crucial for managing skin side effects in metastatic melanoma patients using vemurafenib and ipilimumab.

ARQ-234, a protein designed to treat atopic dermatitis, shows increased effectiveness in early testing.

YH0618 helps reduce chemotherapy-induced hair loss by targeting specific proteins and pathways.

A stronger dual 5α-reductase inhibitor could improve treatment for benign prostatic hyperplasia by further reducing DHT levels.

Cetuximab can cause skin cysts after acne-like eruptions.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

The document concludes that combination therapy is most effective for treating excessive hair growth in women with idiopathic hirsutism, and more research is needed to understand the condition.

Some breast cancer treatments caused long-term hair loss in women, similar to a condition called alopecia areata.

Hair loss is a common, often overlooked side effect of hormone treatments for breast and prostate cancer.

Hormone therapy for prostate cancer can increase heart risks, especially in men with heart conditions.

A woman's male-pattern facial hair growth was caused by a rare malignant ovarian tumor that was difficult to diagnose and treat.

A rare pancreatic tumor caused a woman's male-like features, treated successfully with surgery and medication.

Minoxidil can stop the growth of ovarian cancer cells without harming the heart.

Skin side effects from cancer drugs targeting EGFR can affect treatment adherence but can be managed with antibiotics like tetracycline.

Anti-PD-L1 immunotherapy can cause hair loss and unexpected hair color change, but treatment can restore hair growth and color.

The antibody 005-C04 blocks prolactin receptors, causing reversible infertility, impaired lactation, and hair regrowth in female mice.

A young woman with kidney cancer experienced rare hair loss from a cancer drug and unusual cancer spread, suggesting early drug treatment might reduce spread and prolong survival.

Nanoparticle delivery can reduce side effects of the cancer drug doxorubicin.

Removing the ovarian tumor improved the woman's hormonal symptoms.

Sintilimab with chemotherapy improves survival and response in advanced lung cancer but increases some side effects.

China approved Sinovac's flu vaccine, Japan approved RiUP for female hair loss, and Nippon Kayaku's three cancer drugs.

Cepharanthine may help treat gastric cancer by causing cancer cell death and affecting energy use.

Some chemotherapy can cause permanent hair loss.

Image analysis can effectively identify changes in scalps affected by chemotherapy-induced hair loss.

Curcumin, EGCG, barringtozenol, and finasteride are effective VEGFR inhibitors.

Norethisterone (jenapharm) therapy is effective for endometrial cancer.

The 2006 editorial concluded that immunotherapy was advancing with new drugs, focusing on specific biological therapies and convenient oral treatments, and highlighted the importance of partnerships and new regulations in the field.

Imiquimod shows promise as a non-invasive treatment for certain HPV-related lesions, but more research is needed to optimize its use.

Anastrozole can cause increased testosterone, leading to symptoms like hair growth and thinning.